Skip to main content
. 2022 Apr 6;157(6):e220135. doi: 10.1001/jamasurg.2022.0135

Table 2. Patient Characteristics in Maryland Hospitals and Their Matched Hospitals in Control States.

Patient characteristic Main cohort Major surgery subgroup
No. (%) Standardized difference (95% CI) No. (%) Standardized difference (95% CI)
Maryland (n = 20 320) Control states (n = 4737) Maryland (n = 6858) Control states (n = 1686)
Age at surgery, mean (SD), y 74.9 (6.5) 74.9 (6.5) 0.01 (−0.03 to 0.04) 75.4 (6.3) 75.3 (6.4) 0.01 (−0.04 to 0.06)
Age at surgery, y 0.04 (0.01 to 0.07) 0.06 (0.00 to 0.11)
66-69 5087 (25.0) 1193 (25.2) 1440 (21.0) 374 (22.2)
70-74 5897 (29.0) 1385 (29.2) 1991 (29.0) 487 (28.9)
75-79 4397 (21.6) 1032 (21.8) 1629 (23.8) 378 (22.4)
80-84 2980 (14.7) 665 (14.0) 1159 (16.9) 284 (16.8)
≥85 1959 (9.6) 462 (9.8) 639 (9.3) 163 (9.7)
Sex −0.02 (−0.05 to 0.01) 0.07 (0.01 to 0.12)
Male 6252 (30.8) 1414 (29.9) 3310 (48.3) 869 (51.5)
Female 14 068 (69.2) 3323 (70.1) 3548 (51.7) 817 (48.5)
Race and ethnicity 0.48 (0.45 to 0.52) 0.48 (0.42 to 0.53)
Asian and Pacific Islander 440 (2.2) 58 (1.2) 166 (2.4) 30 (1.8)
Hispanic 304 (1.5) 97 (2.0) 100 (1.5) 35 (2.1)
Non-Hispanic Black 4106 (20.2) 245 (5.2) 1247 (18.2) 69 (4.1)
Non-Hispanic White 15 142 (74.5) 4265 (90.0) 5249 (76.5) 1541 (91.4)
Other 328 (1.6) 72 (1.5) 96 (1.4) 11 (0.7)
Dual eligible at the month of surgery discharge −0.12 (−0.15 to −0.09) −0.14 (−0.19 to −0.09)
No 18 615 (91.6) 4166 (87.9) 6303 (91.9) 1479 (87.7)
Yes 1705 (8.4) 571 (12.1) 555 (8.1) 207 (12.3)
Cancer diagnosis 0.23 (0.20 to 0.26) 0.28 (0.23 to 0.34)
Breasta 8106 (39.9) 2119 (44.7) - -
Colorectal 2711 (13.3) 778 (16.4) 2334 (34.0) 737 (43.7)
Lung 2096 (10.3) 444 (9.4) 1726 (25.2) 405 (24.0)
Prostatea 1237 (6.1) 347 (7.3) - -
Bladder 792 (3.9) 172 (3.6) 520 (7.6) 116 (6.9)
Female genitourinary 1389 (6.8) 255 (5.4) 149 (2.2) 13 (0.8)
Kidney 993 (4.9) 248 (5.2) 801 (11.7) 226 (13.4)
Metastasis 640 (3.1) 88 (1.9) 261 (3.8) 37 (2.2)
Other 2356 (11.6) 286 (6.0) 1067 (15.6) 152 (9.0)
Chronic obstructive pulmonary disease −0.10 (−0.13 to −0.07) −0.16 (−0.21 to −0.11)
No 16 125 (79.4) 3557 (75.1) 4835 (70.5) 1061 (62.9)
Yes 4195 (20.6) 1180 (24.9) 2023 (29.5) 625 (37.1)
Index surgery setting −0.12 (−0.15 to −0.09)
Inpatient 12 210 (60.1) 2566 (54.2)
Outpatient 8110 (39.9) 2171 (45.8)
Surgery type 0.33 (0.27 to 0.38)
Colectomy 2640 (38.5) 790 (46.9)
Cystectomy 316 (4.6) 60 (3.6)
Esophagectomy or gastrectomy 302 (4.4) 46 (2.7)
Lung resection 1899 (27.7) 441 (26.2)
Nephrectomy 1024 (14.9) 280 (16.6)
Pancreatectomy 438 (6.4) 41 (2.4)
Multiple surgeries 239 (3.5) 28 (1.7)
a

Because of small numbers of patients, those in the major surgery subgroup who had breast or prostate cancer were consolidated with the group of patients with other cancers.